Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


March 31, 2015 6:15 PM ET

Pharmaceuticals

Company Overview of Actavis Holdings UK Limited

Company Overview

Actavis Holdings UK Limited operates as a pharmaceutical company that develops, manufactures, and distributes generic, branded, and biosimilar pharmaceutical products. It offers alenvona and cleosensa tablets, neotigason tablets, paracetamol solutions (for infusion), over-the-counter products, and fentanyl transdermal patch solutions. The company provides its products for the treatment of diseases in central nervous system, gastroenterology, women's health, urology, cardiovascular, respiratory, and anti-infective therapeutic categories. It serves patients and healthcare professionals worldwide. Actavis Holdings UK Limited was formerly known as Alpharma Ltd. and changed its name in May 2006. ...

Whiddon Valley

Barnstaple,  EX32 8NS

United Kingdom

Founded in 1903

Phone:

44 12 7131 1200

Fax:

44 12 7134 6106

Key Executives for Actavis Holdings UK Limited

Executive Director of Finance & Information Technology
Managing Director of Operations
Executive Director of Human Resources
Vice President of UK & Ireland
Executive Director of Hospitals & Brands and Director
Compensation as of Fiscal Year 2014.

Actavis Holdings UK Limited Key Developments

Actavis UK Ltd. Wins Multiple Awardees Contract for Supplying Generic Transition Pharmaceuticals

Actavis UK Ltd. won a multiple awardees contract award from The Secretary of State of Health acting as part of the Crown through the Commercial Medicines Unit (part of the Department of Health) for the supply of generic transition pharmaceuticals. The lowest offer is GBP 6.5 million and the highest offer is GBP 7 million.

Actavis UK Wins Multiple Awardees Contract for Supplying Generic Transition Pharmaceuticals

Actavis UK Ltd. won a multiple awardees contract award from The Secretary of State for Health acting as part of the Crown through the Commercial Medicines Unit (part of the Department of Health) for the supply of generic transition pharmaceuticals (Contract Award Notice No.: 2015/S 050-086884). The lowest offer is £14.5 million and the high offer is £14.7 million.

Actavis Announces the Launch of Reltebon (Oxycodone) Prolonged Release Tablets

Actavis has announced the launch of a range of Reltebon (Oxycodone) Prolonged Release tablets which can provide up to a 30% value saving when compared to the originator brand. Available in 5mg x 28, 10mg x 56, 20mg x 56, 40mg x 56, 80mg x 56, Reltebon (Oxycodone) Prolonged Release is used to relieve severe pain, which can only be controlled by opioid analgesics. It is the bioequivalent of the branded originator product, has been manufactured with similar colour and shape tablets and is supplied in simple-to-use push-through blister packs. The launch of Reltebon (Oxycodone) Prolonged Release enhances the Actavis Pain Franchise following on from the launches of Lynlor (Oxycodone) Immediate Release Capsules and Hapoctasin Transdermal Patches (Buprenorphine). Reltebon (Oxycodone) Prolonged Release tablets are manufactured in the Actavis facility based in Barnstaple, UK. All products are available through major wholesalers or directly from the Actavis Telemarketing Team on freephone: 0800-731-0370 or by fax: 0800-731-0380.

Similar Private Companies By Industry

Company Name Region
Aptuit Ltd. Europe
Shire Pharmaceuticals, Ltd. Europe
Synaptica Ltd. Europe
NextPharma Technologies Holding Limited Europe
Phusion Healthcare Limited Europe

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
January 26, 2015
Auden Mckenzie Holdings Limited
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Actavis Holdings UK Limited, please visit www.actavis.co.uk. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.